Skip to main content
Top
Published in: Journal of Cancer Research and Clinical Oncology 8/2010

01-08-2010 | Original Paper

Small interference RNA targeting Krüppel-like factor 8 inhibits the renal carcinoma 786-0 cells growth in vitro and in vivo

Authors: Wei-Jin Fu, Jia-Chu Li, Xiao-yun Wu, Zhan-Bing Yang, Zeng-Nan Mo, Jiong-Wei Huang, Guo-Wei Xia, Qiang Ding, Kang-Da Liu, Hong-Guang Zhu

Published in: Journal of Cancer Research and Clinical Oncology | Issue 8/2010

Login to get access

Abstract

Purpose

Krüppel-like factor 8 (KLF8) plays an important role in oncogenic transformation and is highly overexpressed in several types of human cancer. We investigated the expression of KLF8 in renal cell carcinoma (RCC) tissues and the role of small interference RNA targeting KLF8 on growth, cell cycle, and apoptosis of human renal carcinoma cell line 786-0 in vitro and in vivo.

Methods

The expression of KLF8 protein and mRNA in human renal carcinoma samples was detected by immunochemistry and reverse transcription polymerase chain reaction (RT-PCR). The effects of small interference RNA (siRNA) targeting KLF8 on growth, invasiveness, cell cycle, and apoptosis of 786-0 cells were evaluated by MTT assay, Matrigel Invasion Assay, and flow cytometry in vitro. We also investigated effect of siRNA targeting KLF8 on growth of 786-0 cells in nude mice in vivo.

Results

Immunohistochemistry and RT-PCR results showed the expression of KLF8 protein and mRNA in RCC specimens was significantly higher than that in the adjacent non-tumorous renal tissues (P < 0.001). KLF8-siRNA depressed the cellular growth and invasion of 786-0 cells in vitro. The flow cytometry results revealed that KLF8-siRNA could induce an increase in G0/G1 phase cells and induce cell apoptosis. Intratumor injection of siRNA targeting KLF8 inhibited the growth of 786-0 cells in vivo in nude mice tumor model.

Conclusions

KLF8 possibly involved in regulating the cell growth, invasion, apoptosis, and proliferation of renal carcinoma cancer cells. Blocking the KLF8 channel might be a potential therapeutic strategy for RCC.
Literature
go back to reference Clark JI, Atkins MB, Urba WJ, Creech S, Figlin RA, Dutcher JP, Flaherty L, Sosman JA, Logan TF, White R, Weiss GR, Redman BG, Tretter CP, McDermott D, Smith JW, Gordon MS, Margolin KA (2003) J Clin Oncol 21:3133–3140CrossRefPubMed Clark JI, Atkins MB, Urba WJ, Creech S, Figlin RA, Dutcher JP, Flaherty L, Sosman JA, Logan TF, White R, Weiss GR, Redman BG, Tretter CP, McDermott D, Smith JW, Gordon MS, Margolin KA (2003) J Clin Oncol 21:3133–3140CrossRefPubMed
go back to reference Hu X, Su F, Qin L, Jia W, Gong C, Yu F, Guo J, Song E (2006) Biochem Biophys Res Commun 346:778–785CrossRefPubMed Hu X, Su F, Qin L, Jia W, Gong C, Yu F, Guo J, Song E (2006) Biochem Biophys Res Commun 346:778–785CrossRefPubMed
go back to reference Linehan WM, Vasselli J, Srinivasan R, Walther MM, Merino M, Choyke P, Vocke C, Schmidt L, Isaacs JS, Glenn G, Toro J, Zbar B, Bottaro D, Neckers L (2004) Clin Cancer Res 10:6282S–6289SCrossRefPubMed Linehan WM, Vasselli J, Srinivasan R, Walther MM, Merino M, Choyke P, Vocke C, Schmidt L, Isaacs JS, Glenn G, Toro J, Zbar B, Bottaro D, Neckers L (2004) Clin Cancer Res 10:6282S–6289SCrossRefPubMed
go back to reference Mandriota SJ, Jussila L, Jeltsch M, Compagni A, Baetens D, Prevo R, Banerji S, Huarte J, Montesano R, Jackson DG, Orci L, Alitalo K, Christofori G, Pepper MS (2001) EMBO J 20:672–682CrossRefPubMed Mandriota SJ, Jussila L, Jeltsch M, Compagni A, Baetens D, Prevo R, Banerji S, Huarte J, Montesano R, Jackson DG, Orci L, Alitalo K, Christofori G, Pepper MS (2001) EMBO J 20:672–682CrossRefPubMed
go back to reference McLean GW, Carragher NO, Avizienyte E, Evans J, Brunton VG, Frame MC (2005) Nat Rev Cancer 5:505–515CrossRefPubMed McLean GW, Carragher NO, Avizienyte E, Evans J, Brunton VG, Frame MC (2005) Nat Rev Cancer 5:505–515CrossRefPubMed
go back to reference Messing EM, Manola J, Wilding G, Propert K, Fleischmann J, Crawford ED, Pontes JE, Hahn R, Trump D (2003) J Clin Oncol 21:1214–1222CrossRefPubMed Messing EM, Manola J, Wilding G, Propert K, Fleischmann J, Crawford ED, Pontes JE, Hahn R, Trump D (2003) J Clin Oncol 21:1214–1222CrossRefPubMed
go back to reference O’Sullivan GC, Tangney M, Casey G, Ambrose M, Houston A, Barry OP (2007) Int J Cancer 121:1930–1940CrossRefPubMed O’Sullivan GC, Tangney M, Casey G, Ambrose M, Houston A, Barry OP (2007) Int J Cancer 121:1930–1940CrossRefPubMed
go back to reference Padera TP, Kadambi A, di Tomaso E, Carreira CM, Brown EB, Boucher Y, Choi NC, Mathisen D, Wain J, Mark EJ, Munn LL, Jain RK (2002) Science 296:1883–1886CrossRefPubMed Padera TP, Kadambi A, di Tomaso E, Carreira CM, Brown EB, Boucher Y, Choi NC, Mathisen D, Wain J, Mark EJ, Munn LL, Jain RK (2002) Science 296:1883–1886CrossRefPubMed
go back to reference Rocchi P, Jugpal P, So A, Sinneman S, Ettinger S, Fazli L, Nelson C, Gleave M (2006) BJU Int 98:1082–1089CrossRefPubMed Rocchi P, Jugpal P, So A, Sinneman S, Ettinger S, Fazli L, Nelson C, Gleave M (2006) BJU Int 98:1082–1089CrossRefPubMed
go back to reference Storkel S, Eble JN, Adlakha K, Amin M, Blute ML, Bostwick DG, Darson M, Delahunt B, Iczkowski K (1997) Cancer 80:987–989CrossRefPubMed Storkel S, Eble JN, Adlakha K, Amin M, Blute ML, Bostwick DG, Darson M, Delahunt B, Iczkowski K (1997) Cancer 80:987–989CrossRefPubMed
go back to reference Tschoep K, Kohlmann A, Schlemmer M, Haferlach T, Issels RD (2007) Crit Rev Oncol Hematol 63:111–124CrossRefPubMed Tschoep K, Kohlmann A, Schlemmer M, Haferlach T, Issels RD (2007) Crit Rev Oncol Hematol 63:111–124CrossRefPubMed
go back to reference Wang S, Liu H, Ren L, Pan Y, Zhang Y (2008a) Neoplasia 10:399–407PubMed Wang S, Liu H, Ren L, Pan Y, Zhang Y (2008a) Neoplasia 10:399–407PubMed
Metadata
Title
Small interference RNA targeting Krüppel-like factor 8 inhibits the renal carcinoma 786-0 cells growth in vitro and in vivo
Authors
Wei-Jin Fu
Jia-Chu Li
Xiao-yun Wu
Zhan-Bing Yang
Zeng-Nan Mo
Jiong-Wei Huang
Guo-Wei Xia
Qiang Ding
Kang-Da Liu
Hong-Guang Zhu
Publication date
01-08-2010
Publisher
Springer-Verlag
Published in
Journal of Cancer Research and Clinical Oncology / Issue 8/2010
Print ISSN: 0171-5216
Electronic ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-010-0776-0

Other articles of this Issue 8/2010

Journal of Cancer Research and Clinical Oncology 8/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.